MTOR and acute myeloid leukemia: Primary human AML cells remain proliferative for long-term by growth-enhancing effects of normal MSCs which is mediated by increased phosphorylation of the mammalian or mechanistic target of rapamycin (mTOR) and its downstream targets [125].